Metabolic Reprogramming in Epstein–Barr Virus Associated Diseases
Journal of Medical Virology · 2025-02 · 97 (2)
DOI: 10.1002/jmv.70197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 03.02.2025. Verfasst von Tiffany Melanie Yee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Epstein-Barr Virus Infections, Host-Pathogen Interactions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: This work was supported by SIgN, Agency for Science, Technology and Research (A*STAR) via the A*STAR Biomedical Research Council Central Research Fund-Use-Insp…, Agency for Science, Technology and Research.
Abstract (Originalsprache)
Epstein–Barr virus (EBV) is the first human cancer‐causing viral pathogen to be discovered; it has been epidemiologically associated with a wide range of diseases, including cancers, autoimmunity, and hyperinflammatory disorders. Its evolutionary success is underpinned by coordinated expression of viral transcription factors (EBV nuclear antigens), signaling proteins (EBV latent membrane proteins), and noncoding RNAs, which orchestrate cell transformation, immune evasion, and dissemination. Each of those activities entails significant metabolic rewiring, which is achieved by viral subversion of key host metabolic regulators such as the mammalian target of rapamycin (mTOR), MYC, and hypoxia‐inducible factor (HIF). In this review, we systemically discuss how EBV‐encoded factors regulate metabolism to achieve viral persistence and propagation, as well as potential research questions and directions in EBV‐driven metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Republic of Singapore.
ORCID-Profile: Liang Wei Wang
Förderung
- This work was supported by SIgN, Agency for Science, Technology and Research (A*STAR) via the A*STAR Biomedical Research Council Central Research Fund-Use-Insp…
- Agency for Science, Technology and Research
Zitieren
APA
Yee, T. M., & Wang, L. W. (2025). Metabolic Reprogramming in Epstein–Barr Virus Associated Diseases. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70197
Vancouver
Yee TM, Wang LW. Metabolic Reprogramming in Epstein–Barr Virus Associated Diseases. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70197
BibTeX
@article{Yee2025,
author = {Yee, Tiffany Melanie and Wang, Liang Wei},
title = {Metabolic Reprogramming in Epstein–Barr Virus Associated Diseases},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {2},
doi = {10.1002/jmv.70197}
}
EUVIMED